Non-coding RNAs in the pathophysiology of heart failure with preserved ejection fraction
Heart failure with preserved ejection fraction (HFpEF) is the largest unmet clinical need in cardiovascular medicine. Despite decades of research, the treatment option for HFpEF is still limited, indicating our ongoing incomplete understanding on the underlying molecular mechanisms. Non-coding RNAs,...
Main Authors: | Elisabeth A. Jalink, Amber W. Schonk, Reinier A. Boon, Rio P. Juni |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-01-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2023.1300375/full |
Similar Items
-
The role of coronary microvascular dysfunction in the pathogenesis of heart failure with preserved ejection fraction
by: Becker Al-Khayatt, et al.
Published: (2024-05-01) -
Myocardial RNA Sequencing Reveals New Potential Therapeutic Targets in Heart Failure with Preserved Ejection Fraction
by: José M. Inácio, et al.
Published: (2023-07-01) -
Heart Failure with Preserved Ejection Fraction: The Pathophysiological Mechanisms behind the Clinical Phenotypes and the Therapeutic Approach
by: Laurențiu Stoicescu, et al.
Published: (2024-01-01) -
Worsening effect of testosterone deficiency on males with heart failure with preserved ejection fraction
by: Ahmed Hamam, et al.
Published: (2022-12-01) -
Hydrogen Sulfide as a Potential Therapy for Heart Failure—Past, Present, and Future
by: Kyle B. LaPenna, et al.
Published: (2021-03-01)